Chiles Research Institute
@ChilesResearch
Followers
2K
Following
6K
Statuses
4K
The research division of Providence Cancer Institute Oregon and a Providence Center of Excellence for precision immuno-oncology and cellular therapy.
Portland, Oregon
Joined November 2012
2025 marks a big change for us as @rbryanbell begins his new leadership roles at PCI and @ChilesResearch. He stopped by @KATUNews to share his vision for the future of cancer care. Watch #FINISHCANCER #immunotherapy
0
2
3
@sestant29 is leading pioneering research on a universal vaccine to prevent #breastcancer by targeting early-stage lesions. Learn how immunoprevention could transform cancer care, offering hope for high-risk individuals & solutions for diverse populations.
0
0
0
RT @oncodaily: Earle A. Chiles Research Institute’s tripling of response rates for patients with head and neck cancer – @BernardAFox (@Chil…
0
3
0
Wishing you a holiday season of peace, love, and meaningful moments with family and friends. From all of us at Providence Cancer Institute and Earle A. Chiles Research Institute, happy holidays and best wishes for the new year.
0
0
0
As we prepare to start a new year, we reflect on our commitment to advancing cancer care and research for the benefit of our patients and communities. Looking back, there’s much to celebrate and much more to look forward to. Read about our year:
0
0
1
Be sure to tune in to @KATUNews Afternoon Live today (12/9) at 2:00 p.m. as our @rbryanbell discusses his transition to executive medical director of Providence Cancer Institute and director of the @ChilesResearch. #FINISHCANCER
0
0
3
RT @ACIR_org: Fesneau et al. showed that in HNSCC and CRC tumors, expression of the inhibitor NKG2A, a receptor for HLA-E that is associate…
0
1
0
RT @rbryanbell: Comprehensive Genomic Profiling leads to better patient outcomes in new joint study from @providence @ChilesResearch @illu…
0
3
0
Thanksgiving is more than a holiday, it's an opportunity to appreciate our families, friends, and communities. We thank our @ProvHealth caregivers for their dedication and compassion. To our patients, thank you for entrusting us with your care. Wishing you a Happy Thanksgiving.
0
0
0
RT @rbryanbell: Exchange of information is critical to furthering our mission @ChilesResearch of developing better cancer therapies, which…
0
1
0
RT @OncoDailyIO: IL-12 drives the expression of NKG2A on human tumor-reactive CD8 T cells - Thomas Duhen @Bernard…
0
2
0
RT @rbryanbell: I am deeply honored to succeed Dr. Urba & I am committed to building upon his legacy of transformational immuno-oncology r…
0
5
0
👏Congrats to Thomas Duhen PhD, Olivier Fesneau, PhD and our #FINISHCANCER team for their work just published in @NatureCancer 'IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells'
0
0
2
RT @ProvHealth: Providence is excited to announce Bryan Bell, M.D., as executive medical director of Providence Cancer Institute and direct…
0
1
0
🎉 We're excited to announce that @rbryanbell has accepted the roles of executive medical director of Providence Cancer Institute and director of @ChilesResearch. Dr. Bell will begin serving in his new roles this fall. Read more at
0
1
9
RT @rbryanbell: Delighted to be at @sitcancer Annual Meeting with my colleagues from @ChilesResearch. Congrats to @BernardAFox on his Lifet…
0
1
0
RT @rbryanbell: To my friend & colleague, the indefatigable, insightful, assiduous, brilliant, dedicated, determined, accomplished, respec…
0
9
0
RT @BernardAFox: 💥The Amazing Prof @carlobifulco explains why #AI wins out over humans in evaluating #pathology sections which contain 100x…
0
10
0
🎉Congrats @BernardAFox!
#SITC24 @BernardAFox recognized with well deserved @sitcancer lifetime achievement award. A strong leader and friend. Beacon of progress. Congrats my friend!!! @ProvHealth
0
0
1